News
  • About Us
  • Test serviecs
  • Regulations
  • R & D Service
  • News
  • Contact Us
  • Congratulations to Rainbowlabs for passing the CNAS inspecti

    2015-06-16 15:26:42
    Congratulations to Rainbowlabs for passing the CNAS inspecti
    A good news came that Rainbow Labs passed the site assessment of China National Accreditation Service for Conformity Assessment (CNAS) on November 9, 2014. At present, CNAS is the unique and most authoritative laboratory accreditation certification body. Being approved by CNAS, proves that our level and capacity are up to international standard, product inspection result reliable. The certificate or report issued by us, will be recognized by 56 countries in a mutual recognition system.

    Since then, Rainbow Labs becomes a laboratory which is approved and qualified by the US FDA, Health Canada and CNAS China at the same time. We will constantly make intensified effort on international registration and mutual recognition, unswervingly adhere to the strategy of quality innovation combined with the international high-end market access.
  • comments list

    [MichaelWen  2023-10-03 09:11]  how much is furosemide
    [OscarsIcege  2023-10-03 08:31]  With thanks. An abundance of info. essay writing service review essay services paper writing services legitimate buy essay writing online
    [ManuelTum  2023-10-03 08:26]  Thanks. I value it! dissertation editing services what is a phd buy dissertations dissertation meaning write my essay online do my essay free write my essay ai essay writer graduation thesis https://domyhomeworkformecheap.com
    [Alansefly  2023-10-03 07:49]  can you buy valtrex over the counter
    [DarrylMep  2023-10-03 06:14]  where can i buy doxycycline over the counter
    Total 35921/36135 Pages Frist Prev Prev10 35921  35922   35923   35924   35925   35926   35927   35928   35929   35930  Next10 Next Last

    I want to comment

    content*
    Your name
    Verify code* 
  • Go Top
Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd  Copyright